Cornell scientist says ElleVet Mobility has dramatic beneficial effects in treating arthritis in geriatric patients and is currently being evaluated at the school’s college of veterinary medicine to treat post surgery pain and cancer-related symptoms.


First Clinical Trial of Cannabinoids in Dogs


According to a press release by the drug’s manufacturer, ElleVet Sciences “partnered with Cornell University College of Veterinary Medicine to conduct the first pharmacokinetic study and clinical trial on the use of cannabinoids in dogs with osteoarthritis.”


What are Cannabinoids?


Cannabinoids are chemicals produced by all hemp plants, a group that includes marijuana. There are five major cannabinoids, all of which have been shown to have some therapeutic properties in people and animals. Tetrahydrocannabinol, or THC, is the active ‘high’ ingredient in marijuana. Hemp family plants that are cultivated for high levels of THC are called marijuana plants, while the rest are referred to merely as hemp and are typically cultivated for their fiber. Other cannabinoids in hemp plants include cannabidiol, cannabinol, cannabichromene, and cannabigerol. Cannabidiol, or CBD, the active ingredient in ElleVet Mobility, has received a lot of attention from the medical research community because of its ability to reduce inflammation and pain in the body and for its efficacy in treating anxiety and depression. Unlike THC, CBD has no ‘high’ effect and in fact reduces THC’s pychoactive properties.


Lead Cornell Researcher Endorses ElleVet Mobility 


The veterinarian that led the Cornell study, Dr. Joseph Wakshlag, wrote an enthusiastic letter endorsing ElleVet Mobility to fellow veterinarians who tested the drug at veterinary practices around the United States. Said Dr. Wakshlag: “Over the past 8 months we have conducted a pharmacokinetic and clinical trial on the efficacy of ElleVet Sciences CBD preparation on Osteoarthritis. To date our findings have confirmed that their product is safe and efficacious for pain in dogs with osteoarthritis, chronic joint pain and geriatric pain and soreness with dramatic beneficial effects in our more geriatric patients.” He went on to say, “Considering these very promising initial results, we are continuing our work with ElleVet Mobility examining post-surgical pain, and oncology pain at Cornell University College of Veterinary Medicine.”


ElleVet Mobility in Chew Form


ElleVet Mobility is a soft, palatable chew available in two sizes for dogs above and below 50 pounds in weight. The pill also includes glucosamine and chondroitin, two naturally derived chemicals believed to improve mobility in arthritic dogs. The drug is safe to combine with non-steroidal anti-inflammatories (NSAIDS) like Rimadyl and Deramaxx, but can only be prescribed through a veterinarian. As a reminder, all patients that take NSAIDS routinely to manage arthritis should have a blood test every 6 months to ensure that the drugs are not damaging vital organs like the liver or kidneys. ElleVet Mobility is non-addictive, does not get dogs ‘high’, and cannot be abused by humans, but like any medication should be kept out of reach of children and handled responsibly.   If you have an arthritic dog that you believe would benefit from this drug or any other treatment, please reach out to us. Animal Medical has been successfully managing arthritis in patients for 30 years.   In addition to treating arthritis with medication, we also utilize cold laser therapy, acupuncture and physical therapy, all as a part of the multi-modal approach to pain management offered by our  Physical Medicine Department led by Dr. Lisa Schenkel.